• BSE
  • NSE
Partner with US Open an Demat Account EIPO Portfolio Tracker Watsapp Play Store App Store

News Details

25/05/2026 18:58

Bliss GVS Pharma - General Updates

Bliss GVS Pharma Limited has informed the Exchange about Mr. Santosh Parab (DIN: 01622988) has completed his second and final term as an Independent Director. Consequently, he ceased to be a Director of the Company with effect from the close of business hours on May 25, 2026, and shall also cease to be a member of the Committees with effect from the same date.